Hsiehchen, D., Kainthla, R., Kline, H., Siglinsky, E., Ahn, C., Zhu, H. (2025). Dual TIGIT and PD-1 blockade with domvanalimab plus zimberelimab in hepatocellular carcinoma refractory to anti-PD-1 therapies: the phase 2 LIVERTI trial. Nature Communications. https://doi.org/10.1038/s41467-025-60757-7